Quantcast
Last updated on April 18, 2014 at 15:51 EDT

Latest Adverse effect Stories

Recall Notice Issued For Anemia Drug Omontys
2013-02-25 05:22:08

redOrbit Staff & Wire Reports - Your Universe Online Two pharmaceutical companies have issued a recall of their anemia drug Omontys after receiving reports that some kidney dialysis patients had suffered severe allergic reactions after taking the medication. According to the Associated Press (AP), California-based Affymax Inc. and Illinois-based Takeda Pharmaceutical Co. said some of the more than 25,000 patients who had received the drug had experienced adverse effects afterwards,...

2013-02-22 16:23:04

OTTAWA, Feb. 22, 2013 /CNW/ -The issue: Two unauthorized health products "18 Again" and "Stiff 4 Hours" were tested by Health Canada and were found to contain hidden ingredients (sildenafil or tadalafil) that may pose serious risks to the health of Canadians. The products were being sold at the Unchained Romance booth at the 12(th) Annual Vancouver Taboo Sex Show. These products are promoted as male sexual stimulants and contain hidden prescription medications. Approved drugs...

2013-02-15 16:23:24

SPRINGFIELD, Pa., Feb. 15, 2013 /PRNewswire/ -- Reumofan Plus USA, LLC and Reumofan USA, LLC is recalling "Reumofan Plus" Tablets, Lot# 99515, exp. 09/16, because they contain undeclared active pharmaceutical ingredients: methocarbamol, dexamethasone, and diclofenac. Use of this product could result in serious and life-threatening injuries. Reumofan Plus is used as a treatment for muscle pain, arthritis, osteoporosis, bone cancer and other conditions. This product comes in thirty (30)...

2013-01-30 12:27:33

OTTAWA, Jan. 30, 2013 /CNW/ -The issue: Arbonne International Distribution Inc. is voluntarily recalling one lot (lot 043904) of its RE9 Advanced for Men Facial Moisturizer SPF 20 Sunscreen due to microbial contamination. Product testing undertaken by the company detected bacteria (Aerococcus viridans) that may pose serious health risks to people, especially those with weakened immune systems. Who is affected: Canadians, who have purchased or used this product, especially those...

2013-01-30 12:27:03

Standard will be supported by marketing activities to boost reporting by health professionals OTTAWA, Jan. 30, 2013 /CNW/ - The Honourable Leona Aglukkaq, Minister of Health, today congratulated Accreditation Canada on including, for the first time, guidance on the reporting of adverse drug reactions in its latest Medication Management Standards for health care facilities, including hospitals. "Our Government is committed to protecting the health and safety of Canadians," said...

2013-01-08 16:23:34

OTTAWA, Jan. 8, 2013 /CNW/ - Health Canada today released the January 2013 issue of the Canadian Adverse Reaction Newsletter (CARN). Articles in this issue provide information and guidance to health care professionals on: the risk of convulsions suspected of being associated with the oral laxative Pico-Salax and other products containing sodium picosulfate/magnesium citrate; the antipsychotic drug risperidone and its suspected association with muscle damage independent of neuroleptic...

2013-01-03 16:23:01

PRINCETON, N.J., Jan. 3, 2013 /PRNewswire/ -- TongLi Pharmaceuticals (USA), Inc. (OTCQB: TGLP) today announced that the company has successfully manufactured and will distribute Ginshen Wubao, a dietary food supplement to the domestic and oversea health care markets. Researches indicated that the ingredients of the Ginshen Wubao can support human immunity. The Ginshen Wubao is a TongLi's exclusive patented product. The Ginshen Wubao can support human immunity, especially for aged people and...

2012-12-20 08:26:25

MINNEAPOLIS, Dec. 20, 2012 /PRNewswire/ -- Zimmer Spine, Inc. is initiating a voluntary worldwide recall of all 315 units of the PEEK Ardis® Inserter. The Ardis Inserter is a surgical instrument used during spinal surgery to implant the PEEK Ardis Interbody Spacer. The inserters are being recalled because Zimmer Spine has received reports of PEEK Ardis Interbody Spacer implant breakage when the implant is subjected to excessive lateral and/or off-axis forces from the inserter during...

2012-12-18 16:24:20

SCOTTSDALE, Ariz., Dec. 18, 2012 /PRNewswire/ -- Matrixx Initiatives is voluntarily recalling 1 lot of Zicam® Extreme Congestion Relief nasal gel. The company is taking this step after finding a small amount of Burkholderia cepacia in a single sample of the product taken from the affected lot. The problem was detected during a routine review at the manufacturing facility. Tests on additional samples from the same lot have shown no evidence of the organism. (Photo:...

2012-12-06 20:22:11

HUNTSVILLE, Ala., Dec. 6, 2012 /PRNewswire/ -- Qualitest, a subsidiary of Endo Health Solutions, (Nasdaq: ENDP) today issued a voluntary nationwide recall for 101 lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg. This includes product with the following NDC numbers and lot numbers beginning with the letter "C". NDC Number Bottle Count ---------- ------------ 0603-3888-16 30 ------------...